The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us


8788 John Pappajohn Pavilion
Iowa City IA 52242
(319) 384-7903

Release: Feb. 6, 2001

UI Adult Blood and Marrow Transplantation Program earns accreditation

IOWA CITY, Iowa -- The Holden Comprehensive Cancer Center Adult Blood and Marrow Transplantation Program, along with the Hemopoietic Progenitor Cell Laboratory and the Therapeutic Apheresis Service of the DeGowin Blood Center at the University of Iowa Hospitals and Clinics, recently received accreditation from the Foundation for the Accreditation of Hemopoietic Cell Therapy (FAHCT).

The FAHCT is a nonprofit agency created in 1994 by the International Society of Hemotherapy and Graft Engineering and the American Society of Blood and Marrow Transplantation. Its goal is to ensure that patients receiving blood and marrow stem cell transplants would be cared for at centers providing the highest quality care backed by ongoing research and educational programs.

The Holden Comprehensive Cancer Center Adult Blood and Marrow Transplantation Program is one of 61 accredited centers nationwide and one of four in the states that border Iowa.

"Our program is honored by this accreditation," said Roger Gingrich, M.D., UI professor of internal medicine and associate director of clinical services at the Holden Comprehensive Cancer Center. "But at the same time we recognize the obligation and challenge to continue to provide high quality care in a research environment."

University of Iowa Health Care describes the partnership between the UI College of Medicine and the UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide.